| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MAPK8IP1 MAP9 KRT10 SYNE1 SPTAN1 NUMA1 TOGARAM2 GRIA2 DBN1 KRIT1 IQGAP1 SPTBN5 DST XIRP2 TTLL2 STARD9 SYNE2 DMD PLS1 FMNL1 PACSIN2 | 1.10e-06 | 1099 | 115 | 21 | GO:0008092 |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase (NAD+) activity | 1.36e-06 | 15 | 115 | 4 | GO:0004029 | |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase [NAD(P)+] activity | 2.34e-06 | 17 | 115 | 4 | GO:0004030 | |
| GeneOntologyMolecularFunction | signal sequence binding | 1.10e-05 | 51 | 115 | 5 | GO:0005048 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 1.75e-05 | 56 | 115 | 5 | GO:0016903 | |
| GeneOntologyMolecularFunction | actin filament binding | 5.14e-05 | 227 | 115 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | actin binding | SYNE1 SPTAN1 DBN1 IQGAP1 SPTBN5 DST XIRP2 SYNE2 DMD PLS1 FMNL1 | 1.02e-04 | 479 | 115 | 11 | GO:0003779 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 1.67e-04 | 48 | 115 | 4 | GO:0016620 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 3.25e-04 | 5 | 115 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 3.90e-04 | 25 | 115 | 3 | GO:0017056 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 4.92e-04 | 27 | 115 | 3 | GO:0008139 | |
| GeneOntologyMolecularFunction | peptide binding | 5.13e-04 | 318 | 115 | 8 | GO:0042277 | |
| GeneOntologyMolecularFunction | lipid binding | NPC1 SELP SNX4 NUMA1 CPS1 PLA2G4D KRIT1 IQGAP1 STARD9 APOL3 OSBPL10 LTF SNX9 PACSIN2 ARAP2 | 5.47e-04 | 988 | 115 | 15 | GO:0008289 |
| GeneOntologyMolecularFunction | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity | 1.15e-03 | 9 | 115 | 2 | GO:0043878 | |
| GeneOntologyMolecularFunction | phospholipid binding | SNX4 NUMA1 CPS1 PLA2G4D KRIT1 IQGAP1 OSBPL10 SNX9 PACSIN2 ARAP2 | 1.26e-03 | 548 | 115 | 10 | GO:0005543 |
| GeneOntologyCellularComponent | cortical cytoskeleton | 7.72e-06 | 129 | 116 | 7 | GO:0030863 | |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 1.32e-05 | 93 | 116 | 6 | GO:0030864 | |
| GeneOntologyCellularComponent | Z disc | 1.99e-04 | 151 | 116 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | cell cortex | 2.28e-04 | 371 | 116 | 9 | GO:0005938 | |
| GeneOntologyCellularComponent | supramolecular fiber | MAP9 KRT10 KRT28 SYNE1 SPTAN1 NUMA1 TOGARAM2 DBN1 IQGAP1 DST XIRP2 SYNE2 SCN8A DMD PLS1 LMNTD1 SMTNL2 | 2.71e-04 | 1179 | 116 | 17 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MAP9 KRT10 KRT28 SYNE1 SPTAN1 NUMA1 TOGARAM2 DBN1 IQGAP1 DST XIRP2 SYNE2 SCN8A DMD PLS1 LMNTD1 SMTNL2 | 2.93e-04 | 1187 | 116 | 17 | GO:0099081 |
| GeneOntologyCellularComponent | I band | 3.31e-04 | 166 | 116 | 6 | GO:0031674 | |
| GeneOntologyCellularComponent | sarcomere | 4.84e-04 | 249 | 116 | 7 | GO:0030017 | |
| GeneOntologyCellularComponent | myofibril | 8.34e-04 | 273 | 116 | 7 | GO:0030016 | |
| GeneOntologyCellularComponent | matrix side of mitochondrial inner membrane | 8.36e-04 | 8 | 116 | 2 | GO:0099617 | |
| GeneOntologyCellularComponent | spectrin | 1.07e-03 | 9 | 116 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.18e-03 | 290 | 116 | 7 | GO:0043292 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 1.59e-03 | 90 | 116 | 4 | GO:0016328 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 1.63e-03 | 11 | 116 | 2 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 1.63e-03 | 11 | 116 | 2 | GO:0106094 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 1.63e-03 | 11 | 116 | 2 | GO:0034992 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 1.63e-03 | 11 | 116 | 2 | GO:0034993 | |
| GeneOntologyCellularComponent | astral microtubule | 1.63e-03 | 11 | 116 | 2 | GO:0000235 | |
| GeneOntologyCellularComponent | cell leading edge | 1.90e-03 | 500 | 116 | 9 | GO:0031252 | |
| GeneOntologyCellularComponent | aster | 1.94e-03 | 12 | 116 | 2 | GO:0005818 | |
| GeneOntologyCellularComponent | cuticular plate | 2.29e-03 | 13 | 116 | 2 | GO:0032437 | |
| GeneOntologyCellularComponent | nuclear pore | 2.43e-03 | 101 | 116 | 4 | GO:0005643 | |
| MousePheno | impaired exercise endurance | 6.96e-06 | 68 | 96 | 6 | MP:0012106 | |
| MousePheno | fatigue | 1.55e-05 | 78 | 96 | 6 | MP:0002899 | |
| MousePheno | Purkinje cell degeneration | 1.92e-05 | 81 | 96 | 6 | MP:0000876 | |
| MousePheno | abnormal exercise endurance | 2.53e-05 | 85 | 96 | 6 | MP:0002332 | |
| MousePheno | abnormal neuromuscular synapse morphology | 4.76e-05 | 95 | 96 | 6 | MP:0001053 | |
| MousePheno | abnormal somatic motor system morphology | 5.67e-05 | 98 | 96 | 6 | MP:0001051 | |
| Domain | Spectrin | 4.90e-11 | 23 | 111 | 7 | PF00435 | |
| Domain | Spectrin_repeat | 3.03e-10 | 29 | 111 | 7 | IPR002017 | |
| Domain | ACTININ_2 | 3.57e-09 | 23 | 111 | 6 | PS00020 | |
| Domain | ACTININ_1 | 3.57e-09 | 23 | 111 | 6 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 3.57e-09 | 23 | 111 | 6 | IPR001589 | |
| Domain | CH | 4.59e-09 | 65 | 111 | 8 | SM00033 | |
| Domain | CH | 8.38e-09 | 70 | 111 | 8 | PF00307 | |
| Domain | - | 9.40e-09 | 71 | 111 | 8 | 1.10.418.10 | |
| Domain | CH | 1.18e-08 | 73 | 111 | 8 | PS50021 | |
| Domain | CH-domain | 1.46e-08 | 75 | 111 | 8 | IPR001715 | |
| Domain | SPEC | 3.07e-08 | 32 | 111 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 3.07e-08 | 32 | 111 | 6 | IPR018159 | |
| Domain | Ald_DH_CS_GLU | 2.04e-06 | 16 | 111 | 4 | IPR029510 | |
| Domain | Ald_DH_CS_CYS | 2.65e-06 | 17 | 111 | 4 | IPR016160 | |
| Domain | ALDEHYDE_DEHYDR_CYS | 3.39e-06 | 18 | 111 | 4 | PS00070 | |
| Domain | ALDEHYDE_DEHYDR_GLU | 3.39e-06 | 18 | 111 | 4 | PS00687 | |
| Domain | - | 4.28e-06 | 19 | 111 | 4 | 3.40.605.10 | |
| Domain | Aldedh | 4.28e-06 | 19 | 111 | 4 | PF00171 | |
| Domain | Ald_DH_C | 4.28e-06 | 19 | 111 | 4 | IPR016163 | |
| Domain | Ald_DH_N | 4.28e-06 | 19 | 111 | 4 | IPR016162 | |
| Domain | Ald_DH/histidinol_DH | 4.28e-06 | 19 | 111 | 4 | IPR016161 | |
| Domain | Aldehyde_DH_dom | 4.28e-06 | 19 | 111 | 4 | IPR015590 | |
| Domain | - | 4.28e-06 | 19 | 111 | 4 | 3.40.309.10 | |
| Domain | KASH | 2.08e-04 | 4 | 111 | 2 | IPR012315 | |
| Domain | KASH | 2.08e-04 | 4 | 111 | 2 | PS51049 | |
| Domain | KASH | 2.08e-04 | 4 | 111 | 2 | SM01249 | |
| Domain | KASH | 2.08e-04 | 4 | 111 | 2 | PF10541 | |
| Domain | ERAP1-like_C_dom | 9.57e-04 | 8 | 111 | 2 | IPR024571 | |
| Domain | ERAP1_C | 9.57e-04 | 8 | 111 | 2 | PF11838 | |
| Domain | EF-hand-dom_pair | 1.64e-03 | 287 | 111 | 7 | IPR011992 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 1.16e-05 | 271 | 93 | 10 | MM15406 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.64e-05 | 82 | 93 | 6 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 2.07e-05 | 51 | 93 | 5 | MM15151 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 1.17e-04 | 288 | 93 | 9 | M16864 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.35e-04 | 40 | 93 | 4 | MM14945 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.46e-04 | 121 | 93 | 6 | M872 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.49e-04 | 41 | 93 | 4 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 1.64e-04 | 42 | 93 | 4 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 1.80e-04 | 43 | 93 | 4 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 2.34e-04 | 46 | 93 | 4 | M27397 | |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 2.34e-04 | 46 | 93 | 4 | M39828 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 2.43e-04 | 85 | 93 | 5 | M1870 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 2.55e-04 | 47 | 93 | 4 | MM14939 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 2.56e-04 | 86 | 93 | 5 | MM15413 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 3.00e-04 | 49 | 93 | 4 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 3.24e-04 | 50 | 93 | 4 | MM14610 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 4.68e-04 | 55 | 93 | 4 | MM14917 | |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 5.09e-04 | 24 | 93 | 3 | MM15658 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 5.74e-04 | 58 | 93 | 4 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 5.74e-04 | 58 | 93 | 4 | MM14736 | |
| Pathway | KEGG_GLYCOLYSIS_GLUCONEOGENESIS | 7.39e-04 | 62 | 93 | 4 | M11521 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 8.84e-04 | 65 | 93 | 4 | MM15147 | |
| Pathway | KEGG_HISTIDINE_METABOLISM | 8.97e-04 | 29 | 93 | 3 | M12524 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 9.35e-04 | 114 | 93 | 5 | MM15361 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.05e-03 | 68 | 93 | 4 | MM14968 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.09e-03 | 31 | 93 | 3 | M877 | |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 1.20e-03 | 32 | 93 | 3 | M29579 | |
| Pubmed | MAP9 RANBP2 KRT10 SMARCA5 LSG1 SYNE1 SPTAN1 UTP14A NUMA1 GRIA2 DBN1 PLA2G4D LARP7 IQGAP1 DST AP2B1 STARD9 SYNE2 CFAP74 DMD IL1R1 SNX9 PLS1 TOP2B | 6.21e-11 | 1442 | 116 | 24 | 35575683 | |
| Pubmed | GPI ZNF138 KRT10 SMARCA5 NPEPPS DBN1 CPS1 ZNF836 AP2B1 GYS1 PRKCSH DHTKD1 PLS1 TARS1 | 3.78e-10 | 451 | 116 | 14 | 36168627 | |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 5.16e-10 | 179 | 116 | 10 | 36261009 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | GPI RANBP2 SMARCA5 HSP90AB4P LSG1 NPEPPS SYNE1 SPTAN1 UTP14A NUMA1 DBN1 THOC3 LARP7 IQGAP1 TOMM70 STARD9 PRKCSH LTF TDRD6 TARS1 TOP2B | 9.81e-09 | 1425 | 116 | 21 | 30948266 |
| Pubmed | POM121 inhibits the macrophage inflammatory response by impacting NF-κB P65 nuclear accumulation. | 3.62e-08 | 3 | 116 | 3 | 30802453 | |
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 35507432 | ||
| Pubmed | RANBP2 SMARCA5 NPEPPS SPTAN1 UTP14A NUMA1 LARP7 IQGAP1 DST AP2B1 SYNE2 LTF SNX9 USP47 | 4.11e-08 | 653 | 116 | 14 | 22586326 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | GPI RANBP2 KRT10 HSP90AB4P NPEPPS SPTAN1 DBN1 IQGAP1 DST AP2B1 AGL GYS1 PRKCSH ALDH9A1 SNX9 TARS1 PACSIN2 ALDH7A1 | 5.10e-08 | 1149 | 116 | 18 | 35446349 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | SIN3B RANBP2 RPS6KA5 LSG1 SPTAN1 NAGA LARP7 KRIT1 IQGAP1 SCN8A FMNL1 TOP2B | 7.00e-08 | 475 | 116 | 12 | 31040226 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | GPI RANBP2 SMARCA5 LSG1 NPEPPS RTF2 SPTAN1 UTP14A NUMA1 OAS3 IQGAP1 DST AP2B1 IGKC LTF ALDH9A1 TARS1 TOP2B ALDH7A1 | 1.15e-07 | 1353 | 116 | 19 | 29467282 |
| Pubmed | Two distinct human POM121 genes: requirement for the formation of nuclear pore complexes. | 1.44e-07 | 4 | 116 | 3 | 17900573 | |
| Pubmed | 1.56e-07 | 15 | 116 | 4 | 14697343 | ||
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 1.67e-07 | 120 | 116 | 7 | 31413325 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 3.46e-07 | 197 | 116 | 8 | 20811636 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | GPI KRT10 NPEPPS SYNE1 SPTAN1 NUMA1 POM121C IQGAP1 TOMM70 DST AP2B1 SCN8A PRKCSH TARS1 | 5.34e-07 | 807 | 116 | 14 | 30575818 |
| Pubmed | 5.46e-07 | 20 | 116 | 4 | 21689717 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | GPI KRT10 ANPEP KRT28 NPEPPS NAGA IDUA IQGAP1 MGAT5 FSTL1 ALDH1L2 IGKC LTF ALDH1A3 ALDH9A1 ALDH7A1 | 5.62e-07 | 1070 | 116 | 16 | 23533145 |
| Pubmed | RANBP2 RPS6KA5 SYNE1 SPTAN1 POM121C POM121 DST AP2B1 DMD PACSIN2 SOS2 | 7.46e-07 | 486 | 116 | 11 | 20936779 | |
| Pubmed | GPI SMARCA5 NPEPPS SPTAN1 NUMA1 IQGAP1 AP2B1 AGL PRKCSH SNX9 TARS1 | 8.74e-07 | 494 | 116 | 11 | 26831064 | |
| Pubmed | 9.91e-07 | 23 | 116 | 4 | 18971422 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | GPI RANBP2 KRT10 SMARCA5 LSG1 RTF2 SPTAN1 UTP14A NUMA1 CPS1 IQGAP1 AP2B1 AGL SYNE2 IGKC TARBP1 TARS1 TOP2B | 1.07e-06 | 1415 | 116 | 18 | 28515276 |
| Pubmed | RALGAPA1 GPI MAPK8IP1 MAP9 KRT10 NPEPPS SYNE1 SPTAN1 GRIA2 DBN1 IQGAP1 TOMM70 DST AP2B1 OSBPL10 DMD TARS1 ALDH7A1 | 1.26e-06 | 1431 | 116 | 18 | 37142655 | |
| Pubmed | 1.27e-06 | 234 | 116 | 8 | 36243803 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | GPI RANBP2 SMARCA5 NPEPPS SYNE1 UTP14A NUMA1 IQGAP1 POM121 DST SYNE2 PRKCSH SNX9 TARS1 TOP2B | 1.69e-06 | 1024 | 116 | 15 | 24711643 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | NUMA1 POM121C CCDC141 POM121 AP2B1 XIRP2 SETBP1 NUMB AFF1 SOS2 | 1.91e-06 | 430 | 116 | 10 | 35044719 |
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | 2.76e-06 | 182 | 116 | 7 | 30711629 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GPI SIN3B RANBP2 SMARCA5 LSG1 UTP14A NUMA1 DBN1 POM121C DST AP2B1 NUMB SNX9 TOP2B | 2.95e-06 | 934 | 116 | 14 | 33916271 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RANBP2 RELN KRT10 SMARCA5 LSG1 SYNE1 SPTAN1 UTP14A DBN1 RSRC2 THOC3 DST AP2B1 GYS1 TOP2B | 3.30e-06 | 1082 | 116 | 15 | 38697112 |
| Pubmed | 3.30e-06 | 187 | 116 | 7 | 26460568 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 3.74e-06 | 123 | 116 | 6 | 26912792 | |
| Pubmed | 3.80e-06 | 191 | 116 | 7 | 33762435 | ||
| Pubmed | MAPK8IP1 SIN3B RANBP2 LSG1 NPEPPS SYNE1 SPTAN1 NUMA1 GRIA2 DBN1 IQGAP1 DST AP2B1 SYNE2 | 4.19e-06 | 963 | 116 | 14 | 28671696 | |
| Pubmed | Peripheral macrophage abnormalities in mutant mice with spinocerebellar degeneration. | 4.26e-06 | 10 | 116 | 3 | 1565842 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 4.78e-06 | 477 | 116 | 10 | 31300519 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SIN3B RANBP2 SMARCA5 UTP14A CPS1 RSRC2 RXRB LARP7 TOMM70 AGL SNX9 TOP2B USP47 | 6.01e-06 | 857 | 116 | 13 | 25609649 |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | RANBP2 SPTAN1 NUMA1 IQGAP1 TOMM70 AP2B1 AGL PRKCSH LTF DHTKD1 TARS1 | 6.29e-06 | 607 | 116 | 11 | 39147351 |
| Pubmed | 6.85e-06 | 497 | 116 | 10 | 23414517 | ||
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 7.94e-06 | 38 | 116 | 4 | 12791264 | |
| Pubmed | 1.06e-05 | 86 | 116 | 5 | 37253089 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 11792814 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 1.10e-05 | 2 | 116 | 2 | 24931616 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 22768332 | ||
| Pubmed | Complex N-Linked Glycosylation: A Potential Modifier of Niemann-Pick Disease, Type C1 Pathology. | 1.10e-05 | 2 | 116 | 2 | 35563467 | |
| Pubmed | Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation. | 1.10e-05 | 2 | 116 | 2 | 17267447 | |
| Pubmed | Nesprins: tissue-specific expression of epsilon and other short isoforms. | 1.10e-05 | 2 | 116 | 2 | 24718612 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 24586179 | ||
| Pubmed | Numb3 is an endocytosis adaptor for the inflammatory marker P-selectin. | 1.10e-05 | 2 | 116 | 2 | 19138666 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 17761684 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 31578382 | ||
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | 1.27e-05 | 422 | 116 | 9 | 27342126 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | NPC1 GPI SIN3B RANBP2 SMARCA5 NPEPPS NAGA OAS3 IQGAP1 TOMM70 AGL SYNE2 OSBPL10 NUMB PRKCSH ALDH7A1 | 1.28e-05 | 1367 | 116 | 16 | 32687490 |
| Pubmed | 1.28e-05 | 14 | 116 | 3 | 19874786 | ||
| Pubmed | Role of the AP2 beta-appendage hub in recruiting partners for clathrin-coated vesicle assembly. | 1.28e-05 | 14 | 116 | 3 | 16903783 | |
| Pubmed | GPI SMARCA5 LSG1 NPEPPS SPTAN1 NUMA1 OAS3 RSRC2 THOC3 TRIP4 LARP7 IQGAP1 AP2B1 STARD9 AGL NUMB | 1.32e-05 | 1371 | 116 | 16 | 36244648 | |
| Pubmed | RANBP2 SMARCA5 SPTAN1 NUMA1 DBN1 THOC3 IQGAP1 DST AP2B1 PLS1 TOP2B | 1.37e-05 | 660 | 116 | 11 | 32780723 | |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 1.47e-05 | 235 | 116 | 7 | 28378594 | |
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 1.68e-05 | 333 | 116 | 8 | 32665550 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.77e-05 | 440 | 116 | 9 | 34244565 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | SMARCA5 LSG1 SYNE1 SPTAN1 UTP14A NUMA1 DBN1 CPS1 IQGAP1 DST AP2B1 NUMB LTF | 1.77e-05 | 949 | 116 | 13 | 36574265 |
| Pubmed | GPI RANBP2 SMARCA5 NPEPPS SPTAN1 UTP14A NUMA1 RSRC2 THOC3 TRIP4 LARP7 IQGAP1 AP2B1 AFF1 TARS1 | 1.78e-05 | 1247 | 116 | 15 | 27684187 | |
| Pubmed | 1.96e-05 | 16 | 116 | 3 | 12781685 | ||
| Pubmed | 2.16e-05 | 568 | 116 | 10 | 37774976 | ||
| Pubmed | RANBP2 NPEPPS SPTAN1 NUMA1 OAS3 LARP7 IQGAP1 TOMM70 DST AP2B1 SYNE2 IGKC RWDD1 LTF SNX9 TOP2B | 2.41e-05 | 1440 | 116 | 16 | 30833792 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | RANBP2 SMARCA5 RTF2 NUMA1 CPS1 IQGAP1 AGL GYS1 TIMELESS ALDH9A1 TOP2B | 2.48e-05 | 704 | 116 | 11 | 29955894 |
| Pubmed | NPC1 MAPK8IP1 RELN SYNE1 SPTAN1 USP25 KRIT1 IQGAP1 ZNF836 DST AP2B1 TARBP1 TARS1 USP47 SOS2 | 2.52e-05 | 1285 | 116 | 15 | 35914814 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | 2.58e-05 | 580 | 116 | 10 | 35676659 | |
| Pubmed | 2.60e-05 | 51 | 116 | 4 | 36896912 | ||
| Pubmed | RANBP2 SYNE1 DBN1 IQGAP1 TOMM70 DST AP2B1 DMD ALDH1A3 SNX9 TARS1 SMTNL2 | 2.64e-05 | 844 | 116 | 12 | 25963833 | |
| Pubmed | NPC1 KLHL10 RTF2 SPTAN1 UTP14A GRIA2 CPS1 COA8 DST GYS1 TIMELESS PRKCSH LTF PLS1 LMNTD1 | 2.70e-05 | 1293 | 116 | 15 | 15342556 | |
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 2.84e-05 | 18 | 116 | 3 | 12119179 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | GPI RANBP2 ANPEP SYNE1 NUMA1 CPS1 LARP7 IQGAP1 AP2B1 TIMELESS PRKCSH LTF TOP2B USP47 | 3.18e-05 | 1155 | 116 | 14 | 20360068 |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 28392395 | ||
| Pubmed | The inner nuclear membrane protein Sun1 mediates the anchorage of Nesprin-2 to the nuclear envelope. | 3.30e-05 | 3 | 116 | 2 | 16079285 | |
| Pubmed | A transgenic insertional inner ear mutation on mouse chromosome 1. | 3.30e-05 | 3 | 116 | 2 | 10763993 | |
| Pubmed | LAF4 maps to mouse chromosome 1 and human chromosome 2q11.2-q12. | 3.30e-05 | 3 | 116 | 2 | 8662235 | |
| Pubmed | Patient Mutation Directed shRNA Screen Uncovers Novel Bladder Tumor Growth Suppressors. | 3.30e-05 | 3 | 116 | 2 | 26078295 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 37500615 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 10878022 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 12408964 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 17462627 | ||
| Pubmed | Role of Nesprin-2 and RanBP2 in BICD2-associated brain developmental disorders. | 3.30e-05 | 3 | 116 | 2 | 36930595 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 10576550 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 33472039 | ||
| Pubmed | Nesprins anchor kinesin-1 motors to the nucleus to drive nuclear distribution in muscle cells. | 3.30e-05 | 3 | 116 | 2 | 25516977 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 3.56e-05 | 370 | 116 | 8 | 22922362 | |
| Pubmed | 3.74e-05 | 272 | 116 | 7 | 31010829 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | NPEPPS SPTAN1 USP25 DBN1 TOMM70 DST AP2B1 SETBP1 TDRD6 PACSIN2 | 4.59e-05 | 621 | 116 | 10 | 22794259 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 4.59e-05 | 281 | 116 | 7 | 28706196 | |
| Pubmed | 4.91e-05 | 284 | 116 | 7 | 29459677 | ||
| Pubmed | 5.45e-05 | 634 | 116 | 10 | 34591612 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RANBP2 SMARCA5 RPS6KA5 SPTAN1 NUMA1 DBN1 IQGAP1 AFF1 TIMELESS TOP2B USP47 | 5.84e-05 | 774 | 116 | 11 | 15302935 |
| Pubmed | 5.97e-05 | 641 | 116 | 10 | 36057605 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 16648470 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 10198176 | ||
| Pubmed | Outer nuclear membrane protein Kuduk modulates the LINC complex and nuclear envelope architecture. | 6.59e-05 | 4 | 116 | 2 | 28716842 | |
| Pubmed | Suppression of the NTS-CPS1 regulatory axis by AFF1 in lung adenocarcinoma cells. | 6.59e-05 | 4 | 116 | 2 | 33493519 | |
| Pubmed | LINC complexes mediate the positioning of cone photoreceptor nuclei in mouse retina. | 6.59e-05 | 4 | 116 | 2 | 23071752 | |
| Pubmed | Nesprins, but not sun proteins, switch isoforms at the nuclear envelope during muscle development. | 6.59e-05 | 4 | 116 | 2 | 20108321 | |
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 8954775 | ||
| Pubmed | 6.59e-05 | 4 | 116 | 2 | 19596800 | ||
| Interaction | ARHGAP24 interactions | GPI ZNF138 KRT10 SMARCA5 NPEPPS DBN1 CPS1 ZNF836 AP2B1 GYS1 PRKCSH DHTKD1 PLS1 TARS1 ARAP2 | 1.02e-07 | 486 | 114 | 15 | int:ARHGAP24 |
| Interaction | CHMP4C interactions | GPI SMARCA5 HSP90AB4P NPEPPS SPTAN1 UTP14A DBN1 CPS1 RSRC2 IQGAP1 STARD9 PRKCSH PLS1 TARS1 TOP2B USP47 | 1.61e-06 | 687 | 114 | 16 | int:CHMP4C |
| Interaction | TERF1 interactions | RALGAPA1 SPTAN1 UTP14A NUMA1 DBN1 LARP7 DST SYNE2 TDRD6 DMD PACSIN2 | 4.46e-06 | 347 | 114 | 11 | int:TERF1 |
| Interaction | CLTB interactions | 1.04e-05 | 185 | 114 | 8 | int:CLTB | |
| Interaction | OBSL1 interactions | GPI RANBP2 SMARCA5 ANPEP SYNE1 UTP14A NUMA1 PFKFB4 IDUA LARP7 IQGAP1 POM121 DST SYNE2 GPR156 SNX9 TOP2B | 1.25e-05 | 902 | 114 | 17 | int:OBSL1 |
| Interaction | EMC1 interactions | NPC1 GPI RANBP2 ANPEP NPEPPS GRIA2 CPS1 TOMM70 AGL GYS1 ALDH7A1 | 2.54e-05 | 418 | 114 | 11 | int:EMC1 |
| Interaction | PINK1 interactions | GPI RANBP2 HSP90AB4P NPEPPS SPTAN1 NUMA1 DBN1 PLA2G4D LARP7 IQGAP1 TOMM70 DST IGKC PRKCSH | 2.97e-05 | 679 | 114 | 14 | int:PINK1 |
| Interaction | BAP1 interactions | GPI RANBP2 KRT10 HSP90AB4P NPEPPS SPTAN1 DBN1 CPS1 IQGAP1 DST AP2B1 ALDH1L2 AGL GYS1 PRKCSH ALDH9A1 SNX9 TARS1 PACSIN2 ALDH7A1 | 4.43e-05 | 1314 | 114 | 20 | int:BAP1 |
| Interaction | CDK15 interactions | 5.39e-05 | 117 | 114 | 6 | int:CDK15 | |
| Interaction | BIRC3 interactions | GPI RANBP2 SMARCA5 HSP90AB4P LSG1 NPEPPS SYNE1 SPTAN1 UTP14A NUMA1 DBN1 THOC3 IQGAP1 TOMM70 STARD9 PRKCSH LTF TDRD6 TARS1 TOP2B | 5.47e-05 | 1334 | 114 | 20 | int:BIRC3 |
| Interaction | CIT interactions | GPI RANBP2 SMARCA5 NPEPPS SYNE1 SPTAN1 UTP14A NUMA1 OAS3 DBN1 CPS1 THOC3 IDUA TRIP4 IQGAP1 AP2B1 SYNE2 PLS1 TARBP1 TOP2B SMTNL2 | 5.72e-05 | 1450 | 114 | 21 | int:CIT |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 5.29e-04 | 147 | 115 | 4 | chr15q15 | |
| Cytoband | 17q21 | 5.45e-04 | 63 | 115 | 3 | 17q21 | |
| Cytoband | 7q21.2 | 6.39e-04 | 15 | 115 | 2 | 7q21.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 1.27e-03 | 473 | 115 | 6 | chr17q21 | |
| Cytoband | 7q11.23 | 1.90e-03 | 97 | 115 | 3 | 7q11.23 | |
| Cytoband | 4q32.1 | 1.94e-03 | 26 | 115 | 2 | 4q32.1 | |
| Cytoband | 3q13.33 | 2.58e-03 | 30 | 115 | 2 | 3q13.33 | |
| GeneFamily | Aldehyde dehydrogenases | 9.56e-07 | 19 | 74 | 4 | 398 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 9.86e-05 | 4 | 74 | 2 | 1252 | |
| GeneFamily | EF-hand domain containing|Spectrins | 3.42e-04 | 7 | 74 | 2 | 1113 | |
| GeneFamily | Sorting nexins|PX-BAR domain containing | 1.06e-03 | 12 | 74 | 2 | 1290 | |
| GeneFamily | Aminopeptidases|CD molecules | 2.16e-03 | 17 | 74 | 2 | 104 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RANBP2 SNX4 SMARCA5 NPEPPS TMEM87A KRIT1 MGAT5 DST SYNE2 NUMB AFF1 DMD IL1R1 ARAP2 SOS2 | 5.21e-06 | 856 | 115 | 15 | M4500 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | ATG4A GPI RELN ANPEP SYNE1 NAGA CCDC141 IQGAP1 SAMD9L FSTL1 AGL GYS1 DMD IL1R1 PLS1 ALDH7A1 ARAP2 | 5.87e-06 | 905 | 113 | 17 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-08 | 178 | 115 | 8 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | COVID-19_Moderate-multiplets|COVID-19_Moderate / disease group, cell group and cell class | 1.12e-07 | 147 | 115 | 7 | baf15c773d7751bc6f64d4974a22738626f2b3ff | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.97e-07 | 177 | 115 | 7 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-07 | 182 | 115 | 7 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-07 | 183 | 115 | 7 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-07 | 183 | 115 | 7 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.17e-07 | 189 | 115 | 7 | 94dd5d4d815449feff7ce157fe7f8234f7c81422 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.72e-07 | 199 | 115 | 7 | a1635a52318be0423f8e4fc03d971c28cd22b57e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.63e-06 | 159 | 115 | 6 | 60b1f4dce2ce0911160fda17f137c064da31e2eb | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.70e-06 | 172 | 115 | 6 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.72e-06 | 177 | 115 | 6 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.72e-06 | 177 | 115 | 6 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 6.72e-06 | 177 | 115 | 6 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.72e-06 | 177 | 115 | 6 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.72e-06 | 177 | 115 | 6 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 7.16e-06 | 179 | 115 | 6 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 7.63e-06 | 181 | 115 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-06 | 187 | 115 | 6 | 14c239af77116d28d511dea754b6150d20488080 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.77e-06 | 189 | 115 | 6 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | control-Myeloid-Immature_Neutrophils_1|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.01e-05 | 190 | 115 | 6 | 38e83337c70c8734b63f8589ba59e0f98603f94c | |
| ToppCell | IPF-Epithelial-Goblet|Epithelial / Disease state, Lineage and Cell class | 1.04e-05 | 191 | 115 | 6 | 267e1192aaec468c1a59eb24848b37e0e18cbc44 | |
| ToppCell | control-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.07e-05 | 192 | 115 | 6 | 9f12b79d661ef0f57c2c924e8ecc24a46ea996d2 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.10e-05 | 193 | 115 | 6 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-Developing_Neutrophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.17e-05 | 195 | 115 | 6 | de23409b1b4146b8ae286850b829ec8dceed0117 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.17e-05 | 195 | 115 | 6 | becad890a420267ca41e98e61a8da343b51e1945 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-05 | 197 | 115 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.24e-05 | 197 | 115 | 6 | 9599319dd1f80c81356a8624131566cc76d77d7e | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 1.27e-05 | 198 | 115 | 6 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | CV|World / Virus stimulation, Condition and Cluster | 1.27e-05 | 198 | 115 | 6 | 6a28193af35abec5c029129930c2ca6febaafde2 | |
| ToppCell | CD8+_Memory_T_cell-CV|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.27e-05 | 198 | 115 | 6 | 3d1749f5106f0912f4a74615863853949f52c73d | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-05 | 198 | 115 | 6 | 1fe60443c11d34b6d2671af8f06e0dedc8d1558b | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.31e-05 | 199 | 115 | 6 | 5919933c4b842b98fc98685dc8c72c8dd32c6ea3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-05 | 199 | 115 | 6 | 85bb28369e0568b7b3bda095722102fc793f60ef | |
| ToppCell | COVID-19_Severe-immature_Neutrophil|COVID-19_Severe / Disease condition and Cell class | 1.31e-05 | 199 | 115 | 6 | f82fa9d651e78f9ebbe6264e00a48c54b1786a69 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil-|COVID-19_Severe / Disease condition and Cell class | 1.31e-05 | 199 | 115 | 6 | 42ea0c19c455bdb0ae89b428d09c333104c670dc | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.31e-05 | 199 | 115 | 6 | caf2e050b21e7a16ce4e51b3f135debd06810231 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 200 | 115 | 6 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.35e-05 | 200 | 115 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 2.66e-05 | 135 | 115 | 5 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | LPS-antiTNF-Myeloid-Myeloid_granulocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.50e-05 | 143 | 115 | 5 | 4a0f26eef935fe68a1da5d319503059a8a8682dd | |
| ToppCell | LPS-antiTNF-Myeloid-Myeloid_granulocytic-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.50e-05 | 143 | 115 | 5 | 65328a0a2f3972fac596e07933e74b2ef7cceb84 | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 5.30e-05 | 156 | 115 | 5 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B-ABC_aged-B_memory|Lung / Manually curated celltypes from each tissue | 5.81e-05 | 159 | 115 | 5 | d3202ddc291b8686dbe67690df13c7daffec2199 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 6.53e-05 | 163 | 115 | 5 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.72e-05 | 164 | 115 | 5 | 6e6aedb61f8e195d52e028fdda750a29bb14e57e | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.19e-05 | 171 | 115 | 5 | ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6 | |
| ToppCell | normal-na-Lymphocytic_NK-natural_killer_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.19e-05 | 171 | 115 | 5 | d339840626211a7bf1a9eb8f14d6c9509ab05e1c | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.19e-05 | 171 | 115 | 5 | 97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 8.19e-05 | 171 | 115 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | Basal_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 8.89e-05 | 174 | 115 | 5 | a0060be3940043015dcc49a5157de5541aed24a1 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.13e-05 | 175 | 115 | 5 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.38e-05 | 176 | 115 | 5 | e08e7a6dd0208acfbb8646d71915af822a64b5de | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.38e-05 | 176 | 115 | 5 | b8264cdda75c5145d8bf8ae00b3e05393fe9a92b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.38e-05 | 176 | 115 | 5 | 4aee9fdada077db7e531684ab938153f84dc8146 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.89e-05 | 178 | 115 | 5 | 15a99080e9f669572ab6d82934f324e6714846c1 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.89e-05 | 178 | 115 | 5 | 200308e109abb7e6f8816a6f8cce6d56862d4098 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.02e-04 | 179 | 115 | 5 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-04 | 179 | 115 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Control-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 1.04e-04 | 180 | 115 | 5 | 47036eee4c128fbb443d1fc767b4de5cced93f0e | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 181 | 115 | 5 | 566249e04dd491e6287ad2101b7b1ab11031ed8b | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 181 | 115 | 5 | db9528dc7cb0230e4c36cb27da69102c588c7ee9 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.10e-04 | 182 | 115 | 5 | 52eac2f892ea7f26731e0b21c578fd2665a1657a | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 1.10e-04 | 182 | 115 | 5 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.10e-04 | 182 | 115 | 5 | 1aea96ee211f7b9caef7fd385233f51be6021a73 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 182 | 115 | 5 | 9025178ede571e3808d4657ad4892152f336c9b4 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 182 | 115 | 5 | c075756cd4bb484ede1be2bcdb9eac60eab0573a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.10e-04 | 182 | 115 | 5 | b427e43ee523a3ea9eca3207f3d82042f10f022a | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.10e-04 | 182 | 115 | 5 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-04 | 182 | 115 | 5 | c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-04 | 182 | 115 | 5 | 4cb182ef39be2044a6ad7266f332d4177591e550 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Mild / Disease group, lineage and cell class | 1.13e-04 | 183 | 115 | 5 | 7717fce227b4e02ed41baad8ae7dd2e22bd7c13e | |
| ToppCell | Control-Epithelial-Goblet|Epithelial / Disease state, Lineage and Cell class | 1.13e-04 | 183 | 115 | 5 | bdd461349a1ef43a015843937d26e8d3571ecc22 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-04 | 183 | 115 | 5 | f079179f2984def91ddf0b33d7949d5ecdbd380d | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 1.13e-04 | 183 | 115 | 5 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-04 | 183 | 115 | 5 | 49e8ee16e4f677f9f649e2a2faf1b9b16c5a27e7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 184 | 115 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 184 | 115 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 184 | 115 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 184 | 115 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control-immature_Neutrophil-|Control / Disease condition and Cell class | 1.16e-04 | 184 | 115 | 5 | c4e8ba82a6aa76c46f05a71d5f1c7926555318cf | |
| ToppCell | Control-immature_Neutrophil|Control / Disease condition and Cell class | 1.16e-04 | 184 | 115 | 5 | 2fdae5c6b3eb2232881d933a8c1061fda3623016 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.16e-04 | 184 | 115 | 5 | d9659d1e4465fec68f48a22edef443f354f6c7cf | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.16e-04 | 184 | 115 | 5 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 1.19e-04 | 185 | 115 | 5 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_1|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.19e-04 | 185 | 115 | 5 | d747bc91fc276f12a5572ab0223fc71f829a5110 | |
| ToppCell | VE-Treg-CD4_Treg|VE / Condition, Cell_class and T cell subcluster | 1.28e-04 | 188 | 115 | 5 | fa88ceb336e30de3585e62608527a0d44df74190 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.28e-04 | 188 | 115 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 1.28e-04 | 188 | 115 | 5 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.28e-04 | 188 | 115 | 5 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Undetermined|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.28e-04 | 188 | 115 | 5 | 0ddc5dbe2fd905fee20c33d9845629e259faacd9 | |
| ToppCell | VE-Treg|VE / Condition, Cell_class and T cell subcluster | 1.28e-04 | 188 | 115 | 5 | ef048517dfe2fc995d13eb1f08106a487354a4cc | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.28e-04 | 188 | 115 | 5 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.28e-04 | 188 | 115 | 5 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.31e-04 | 189 | 115 | 5 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.31e-04 | 189 | 115 | 5 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 189 | 115 | 5 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 189 | 115 | 5 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 1.31e-04 | 189 | 115 | 5 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 1.31e-04 | 189 | 115 | 5 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.31e-04 | 189 | 115 | 5 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| Computational | Genes in the cancer module 119. | 5.45e-05 | 143 | 74 | 7 | MODULE_119 | |
| Computational | Oxidoreductases. | 1.08e-04 | 14 | 74 | 3 | MODULE_464 | |
| Computational | Genes in the cancer module 194. | 1.34e-04 | 15 | 74 | 3 | MODULE_194 | |
| Computational | Genes in the cancer module 171. | 3.64e-04 | 138 | 74 | 6 | MODULE_171 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.75e-04 | 50 | 74 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | 3-aminopropanal | 3.71e-07 | 30 | 114 | 5 | CID000000075 | |
| Drug | plakin | 3.55e-06 | 82 | 114 | 6 | CID000018752 | |
| Drug | 3-butynoate | 4.22e-06 | 7 | 114 | 3 | CID000137547 | |
| Drug | 3-butynal | 4.22e-06 | 7 | 114 | 3 | CID000142966 | |
| Drug | C04554 | 6.72e-06 | 8 | 114 | 3 | CID000440384 | |
| Drug | netropsin | 8.98e-06 | 56 | 114 | 5 | CID000004461 | |
| Drug | CPD 30 | 1.00e-05 | 9 | 114 | 3 | CID000440850 | |
| Drug | 4-acetamidobutyrate | 1.00e-05 | 9 | 114 | 3 | CID000018189 | |
| Drug | ynoate | 1.96e-05 | 11 | 114 | 3 | CID000010110 | |
| Drug | damnacanthol | 2.49e-05 | 2 | 114 | 2 | CID000160474 | |
| Drug | AC1NSWD2 | 2.49e-05 | 2 | 114 | 2 | CID005318091 | |
| Drug | acephylline | 2.49e-05 | 2 | 114 | 2 | CID000069550 | |
| Drug | rubiadin-1-methyl ether | 2.49e-05 | 2 | 114 | 2 | CID000096191 | |
| Drug | imidazole acetaldehyde | 2.60e-05 | 12 | 114 | 3 | CID000150841 | |
| Drug | 9-cis-acitretin | 2.88e-05 | 71 | 114 | 5 | CID000041317 | |
| Drug | maleimide | 5.19e-05 | 131 | 114 | 6 | CID000010935 | |
| Drug | 6-[(3R,7R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanal | 5.32e-05 | 15 | 114 | 3 | CID000440673 | |
| Drug | Terazosin hydrochloride [63590-64-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 5.95e-05 | 196 | 114 | 7 | 7187_DN | |
| Drug | Atropine-N-oxide hydrochloride [4574-60-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 6.35e-05 | 198 | 114 | 7 | 6812_DN | |
| Drug | Myricetin [529-44-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 6.35e-05 | 198 | 114 | 7 | 3270_UP | |
| Drug | glycurone | 6.53e-05 | 16 | 114 | 3 | CID000003483 | |
| Drug | Ribostamycin sulfate salt [53797-35-6]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 6.55e-05 | 199 | 114 | 7 | 6765_DN | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; MCF7; HT_HG-U133A | 6.55e-05 | 199 | 114 | 7 | 4346_DN | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 6.76e-05 | 200 | 114 | 7 | 3425_UP | |
| Drug | ethyl bromodifluoroacetate | 7.43e-05 | 3 | 114 | 2 | CID000069585 | |
| Drug | moxaverine | 7.43e-05 | 3 | 114 | 2 | CID000070881 | |
| Drug | 2byi | 7.43e-05 | 3 | 114 | 2 | CID005327104 | |
| Drug | glyceraldehyde | 7.51e-05 | 140 | 114 | 6 | CID000000751 | |
| Drug | ethanol | SELP GPI SPTAN1 GRIA2 OAS3 ADCY2 KRIT1 SPTBN5 GYS1 APOL3 LTF ALDH1A3 ALDH9A1 ALDH7A1 | 7.65e-05 | 837 | 114 | 14 | CID000000702 |
| Drug | trimethylaminobutyraldehyde | 7.90e-05 | 17 | 114 | 3 | CID000000133 | |
| Drug | propynal | 7.90e-05 | 17 | 114 | 3 | CID000012222 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 8.68e-05 | 4 | 113 | 2 | cv:CN293514 | |
| Disease | Bipolar Disorder | 9.45e-05 | 477 | 113 | 9 | C0005586 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 1.44e-04 | 5 | 113 | 2 | C1450051 | |
| Disease | Myositis, Proliferative | 1.44e-04 | 5 | 113 | 2 | C0544796 | |
| Disease | Cerebellar Ataxia | 1.44e-04 | 5 | 113 | 2 | C0007758 | |
| Disease | Infectious Myositis | 1.44e-04 | 5 | 113 | 2 | C0158353 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 1.44e-04 | 5 | 113 | 2 | C0410190 | |
| Disease | Cone-Rod Dystrophies | 1.44e-04 | 5 | 113 | 2 | C4085590 | |
| Disease | Myositis | 1.44e-04 | 5 | 113 | 2 | C0027121 | |
| Disease | Myositis, Focal | 1.44e-04 | 5 | 113 | 2 | C0751357 | |
| Disease | Idiopathic Inflammatory Myopathies | 1.44e-04 | 5 | 113 | 2 | C0751356 | |
| Disease | intellectual disability (is_implicated_in) | 2.06e-04 | 30 | 113 | 3 | DOID:1059 (is_implicated_in) | |
| Disease | Emery-Dreifuss muscular dystrophy | 2.16e-04 | 6 | 113 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 2.16e-04 | 6 | 113 | 2 | C0410189 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 3.01e-04 | 7 | 113 | 2 | C0751337 | |
| Disease | unipolar depression, bipolar disorder | 3.43e-04 | 156 | 113 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | influenza A (H1N1) | 3.55e-04 | 87 | 113 | 4 | EFO_1001488 | |
| Disease | Gastrointestinal Hemorrhage | 5.14e-04 | 9 | 113 | 2 | C0017181 | |
| Disease | 1-ribosyl-imidazoleacetate measurement | 5.14e-04 | 9 | 113 | 2 | EFO_0800034 | |
| Disease | insulin sensitivity measurement, glucose homeostasis measurement | 6.04e-04 | 43 | 113 | 3 | EFO_0004471, EFO_0006896 | |
| Disease | Malignant neoplasm of breast | GPI SYNE1 SPTAN1 PFKFB4 DBN1 RXRB CSF1 SETBP1 SYNE2 AFF1 TIMELESS DMD | 8.59e-04 | 1074 | 113 | 12 | C0006142 |
| Disease | open-angle glaucoma | 8.60e-04 | 191 | 113 | 5 | EFO_0004190 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 9.36e-04 | 12 | 113 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Candidemia | 9.36e-04 | 12 | 113 | 2 | EFO_1001282 | |
| Disease | anti-basement membrane glomerulonephritis (implicated_via_orthology) | 1.28e-03 | 14 | 113 | 2 | DOID:4780 (implicated_via_orthology) | |
| Disease | Tremor, Rubral | 1.68e-03 | 16 | 113 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 1.68e-03 | 16 | 113 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 1.68e-03 | 16 | 113 | 2 | C0278161 | |
| Disease | Ataxia, Sensory | 1.68e-03 | 16 | 113 | 2 | C0240991 | |
| Disease | central nervous system disease (implicated_via_orthology) | 1.68e-03 | 16 | 113 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | Abnormal coordination | 1.68e-03 | 16 | 113 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 1.68e-03 | 16 | 113 | 2 | C0427190 | |
| Disease | hypertension, white matter hyperintensity measurement | 1.75e-03 | 62 | 113 | 3 | EFO_0000537, EFO_0005665 | |
| Disease | mean platelet volume | NPEPPS UTP14A NUMA1 PFKFB4 CPS1 COMMD6 AP2B1 SETBP1 SYNE2 AFF1 PACSIN2 | 1.87e-03 | 1020 | 113 | 11 | EFO_0004584 |
| Disease | Myeloid Leukemia | 2.14e-03 | 18 | 113 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 2.14e-03 | 18 | 113 | 2 | C0023466 | |
| Disease | bipolar I disorder | 2.15e-03 | 141 | 113 | 4 | EFO_0009963 | |
| Disease | Grand Mal Status Epilepticus | 2.19e-03 | 67 | 113 | 3 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 2.19e-03 | 67 | 113 | 3 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 2.19e-03 | 67 | 113 | 3 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 2.19e-03 | 67 | 113 | 3 | C0751523 | |
| Disease | Petit mal status | 2.19e-03 | 67 | 113 | 3 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 2.19e-03 | 67 | 113 | 3 | C0393734 | |
| Disease | Status Epilepticus | 2.29e-03 | 68 | 113 | 3 | C0038220 | |
| Disease | Manic Disorder | 2.59e-03 | 71 | 113 | 3 | C0024713 | |
| Disease | ST2 protein measurement | 2.91e-03 | 21 | 113 | 2 | EFO_0010599 | |
| Disease | advanced glycosylation end product-specific receptor ligand measurement | 2.91e-03 | 21 | 113 | 2 | EFO_0010762 | |
| Disease | Liver Cirrhosis, Experimental | 2.97e-03 | 774 | 113 | 9 | C0023893 | |
| Disease | Down syndrome (is_marker_for) | 3.19e-03 | 22 | 113 | 2 | DOID:14250 (is_marker_for) | |
| Disease | Manic | 3.38e-03 | 78 | 113 | 3 | C0338831 | |
| Disease | insulin sensitivity measurement | 3.49e-03 | 23 | 113 | 2 | EFO_0004471 | |
| Disease | Depression, Bipolar | 3.50e-03 | 79 | 113 | 3 | C0005587 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FAKDVLDQWSQLEKD | 51 | Q6P461 | |
| VNLAVQNAKAAFKIW | 51 | P49189 | |
| VAQVLKKLALFDEWN | 151 | Q8WYN0 | |
| EVWNEAEAKADLQKV | 276 | Q9NZN9 | |
| SEDWNIFDVKQANAI | 51 | Q8IVU9 | |
| WKDIPNENELQFQIK | 841 | P63010 | |
| KIQFAIAADDNAEFW | 181 | Q6L9W6 | |
| FKFKNEEEVFAWNNE | 436 | P49419 | |
| EEEVFAWNNEVKQGL | 441 | P49419 | |
| QKKENAEISWDQSAE | 226 | Q3SY69 | |
| NLEVKFTKIFINNEW | 26 | P47895 | |
| NQFEEESKPWKVVEA | 381 | Q86UQ4 | |
| KRANDFWAGNLQKDE | 761 | Q8WZ64 | |
| VKENKEVVLQWFTEN | 951 | P15144 | |
| EALSQLDFQWEKVNK | 2076 | P11532 | |
| QLQSQDEKDWFAKRF | 136 | Q96HY7 | |
| WQSNKDTQEAQKFAL | 611 | P46940 | |
| EEKEKNRQVEFQAAW | 131 | P36021 | |
| NLNFEFQVAKKEGSW | 1341 | P49792 | |
| EQNRKDAEAWFNEKS | 271 | Q7Z3Y7 | |
| QNRKDAEAWFNEKSK | 331 | P13645 | |
| NLTAVEKWNEKKEAF | 556 | Q49MG5 | |
| EELKQAEKDNFLEWR | 126 | Q9H089 | |
| ADAWIQAIKSLAEKQ | 246 | Q09328 | |
| ALAKNSDWVDQFRVK | 556 | Q9UQF2 | |
| RDFQAWLDTKKEEQN | 4856 | Q03001 | |
| KLWEEQLAAAKAQQE | 196 | P14314 | |
| QVANSAFVEQEWKKG | 401 | Q58FF6 | |
| KQLQFFQDVSDWLEK | 786 | Q76MJ5 | |
| IFSNADLKLQDEWKV | 4516 | Q2LD37 | |
| FDKWQTESNDKENEK | 2841 | Q5CZC0 | |
| LQAVLDSAAEKKWQV | 161 | P42262 | |
| WKAENEAFTLADLKQ | 166 | Q96I76 | |
| SEEEKVAFVNWINKA | 121 | Q14651 | |
| AQFISDQNIKDLKVW | 286 | Q16877 | |
| FKDQVAALSWVQKNI | 196 | Q6NT32 | |
| VKQVLADIAKQVDFW | 31 | Q4G0J3 | |
| CEENKQNNWEEAAKL | 396 | O00522 | |
| QNNWEEAAKLLKEAI | 401 | O00522 | |
| KQAWEKLDADVEFNR | 256 | Q8N9Z9 | |
| NAETAKEWFLQAAKD | 221 | P06744 | |
| EAWKNVSQEAKDLIQ | 651 | O75582 | |
| NREQFWEQAKKEEEL | 176 | Q16643 | |
| AKSDVTNQLVDFQWK | 11 | Q7Z4G1 | |
| NNGKKEEIWIVDDFI | 1931 | P78509 | |
| EKKASLQWFNQALED | 516 | A8CG34 | |
| DLEKKASLQWFNQAL | 121 | A6NF01 | |
| KLQRAQAWEKEFINF | 576 | O15118 | |
| LDLEKKASLQWFNQA | 536 | Q96HA1 | |
| NDDFEKIKNWQKEAF | 106 | Q9UNF0 | |
| RGFQEENKALWENNK | 391 | Q8NA61 | |
| IDGINAQKQWLKSED | 561 | Q08462 | |
| WKAVNTLNEALEFAK | 1106 | P31327 | |
| NVKQEDAVFEAILKW | 196 | Q6JEL2 | |
| VERNTWLKKANEFFN | 346 | Q6ZP82 | |
| NVFNETKNLLDKDWN | 151 | P09603 | |
| DENADWKLSFQEFLK | 206 | Q12841 | |
| VQQKDEQFREWFLKE | 141 | O95236 | |
| TDFEDKQQVFEWKDL | 141 | P35475 | |
| EAKVQWKVDNALQSG | 36 | P01834 | |
| TKKALTNEAENWADN | 106 | P16109 | |
| EQEVEQWKKEAAAQE | 1001 | O95466 | |
| QLKQWKAFEEENQTI | 311 | Q8NFN8 | |
| NAVLFEVAWEVANKV | 26 | P13807 | |
| AQEIQSTWLEFKAKA | 441 | Q92902 | |
| AEQAAEFKKRWTQFV | 651 | Q8IZU8 | |
| EFFKNENNELPKLQW | 146 | P14778 | |
| TKFQQKNAATEDLWE | 466 | P55786 | |
| KFQAWDRAKAELAEQ | 301 | Q9C0B2 | |
| GQELKAWQEKFFQKE | 1326 | Q14980 | |
| AWQEKFFQKEQALST | 1331 | Q14980 | |
| QQERQFEVKFEVSKW | 851 | Q9Y6K5 | |
| NVKENNLETLDFKEW | 466 | Q86XP0 | |
| FEAQWAALENKSKQR | 616 | P49757 | |
| VEKVDKDAELVAQWN | 21 | Q9BY42 | |
| EKQLENSLNEFGEKW | 516 | P26639 | |
| AEIWEKLNFGNKDQN | 351 | Q7L4I2 | |
| KNAWADIERFKEQKN | 401 | O95219 | |
| QQFLNFRDEKEWKTG | 351 | Q9Y5X1 | |
| SIIFAAKSAEEKNNW | 521 | Q07890 | |
| KAIQAFNEFIDNAWQ | 901 | O60522 | |
| TWVTLFDQNNAAKKE | 21 | Q02880 | |
| NNNEAWAKDLKLADF | 576 | P02788 | |
| KAFRDFQQWLVNAKI | 3071 | Q8NF91 | |
| ALWDKLFNLKNVIDE | 1646 | Q8WXH0 | |
| LFNLKNVIDEWTEKA | 1651 | Q8WXH0 | |
| NFNDWFSNIKVNLKE | 1846 | Q8WXH0 | |
| QDSNKKVNQWALESF | 816 | Q6ZUX3 | |
| EKDFNTALDWARQAK | 1096 | Q8IVG5 | |
| AKEEEWREAQQGFNK | 576 | O75182 | |
| AAKELEFDQAWISQQ | 671 | Q9P2P6 | |
| LRAADAKEKQFWVTQ | 151 | Q9BXB5 | |
| KVQEAWATLQAKAQE | 3291 | Q9NRC6 | |
| QAADKQLFTLVEWAK | 341 | P28702 | |
| FDLWEQAEALTRKNK | 1156 | P51825 | |
| WANQNLTFSKEKEEF | 111 | Q96IL0 | |
| DVQKGDVKQAVWLFE | 1306 | A4UGR9 | |
| AAVNQKAFVELLFWK | 781 | Q9UNS1 | |
| DLWLEQNIKDSFQKV | 21 | P52744 | |
| EWKNKENQERGFSFL | 226 | Q6GYQ0 | |
| LADQWQFLVQKSAEK | 1636 | Q13813 | |
| KLDENSAFLQFNWKA | 1971 | Q13813 | |
| ELQQQFAKAKATWET | 766 | O94964 | |
| FAKVQEKTQILNEEW | 46 | Q92800 | |
| KAEEQFKFEVNEISW | 176 | Q96J01 | |
| FDALEQKWKQTEQAD | 281 | Q96K76 | |
| FEKELEEWDAQLAQK | 696 | Q9UHP3 | |
| EEWDAQLAQKALQEK | 701 | Q9UHP3 | |
| EAQARKALFEKWEQE | 311 | Q2TAL5 | |
| EIRWKNVKINFDNVG | 1386 | Q9UQD0 | |
| AAFEQLQKWKEVAQD | 161 | O94826 | |
| RGWNKFDKQEQNAED | 106 | Q9BWV7 | |
| EVAFNKTAQVLSKWD | 131 | Q9BVJ6 | |
| NWEAADLGNEERKQK | 26 | O00193 | |
| ASIGEKWKDQNIEDQ | 41 | Q08AG5 | |
| GQFIEELITKWQKND | 61 | Q15650 | |
| NKFDVTWKQAKDIVQ | 611 | Q9WJR5 | |
| ADNQAEWTDVQKKII | 1421 | Q13395 | |
| NQFIKANEKWGRDDI | 851 | O60264 | |
| VTIENFLNWKAKFDA | 146 | Q9H446 | |
| DLDWVKNAQKAFDNT | 351 | Q9Y6X0 | |
| DEWQKELYNNLVKEN | 216 | Q9UDV7 | |
| NKAQEDDLKWVEENV | 511 | Q8NBN3 | |
| IQKNLQDLEFQWKDG | 91 | Q6ZNA1 | |
| LKLWEFFQVDVNKAV | 296 | P35573 | |
| DKVVQDAQTFAEWKV | 136 | P17050 |